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Abstract 
 
The brain has the ability to sense, coordinate and respond to environmental changes through 
biological processes involving activity-dependent gene expression. CREB-regulated transcription 
coactivators (CRTCs) have recently emerged as novel transcriptional regulators of essential 
biological functions, while their deregulation is linked to age-related human diseases. In the brain, 
CRTCs are unique signaling factors that act as sensors and integrators of hormonal, metabolic, and 
neural signals contributing to brain plasticity and brain-body communication. In this review, we 
focus on the regulatory mechanisms and functions of CRTCs in brain metabolism, lifespan, 
circadian rhythm and synaptic mechanisms underlying memory and emotion. We also discuss how 
CRTCs deregulation in cognitive and emotional disorders may provide the basis for potential clinical 
and therapeutic applications in neurodegenerative and psychiatric diseases. 
 
 
 
 
 
Trends 
 
 CRTCs are novel regulators of neuronal circuits and brain-body communication. 
 CRTC1 regulates neuroplasticity genes involved in synaptic plasticity, memory and emotional 
processes. 
 CRTC1 dysfunction is linked to psychiatric and age-related neurodegenerative diseases. 
 CRTCs are novel potential genetic factors and therapeutic targets for psychiatric and 
neurodegenerative diseases. 
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“Mens sana in corpore sano” (Satire X, Decimus Iūnius Iuvenālis), assumes that healthy mind exists in a 
healthy body, whereas harmful habits or diseases impact negatively on mind and brain function. 
Brain-body communication is vital for health status and when disrupted, especially in chronic 
degenerative or psychiatric illnesses, it influences negatively on body function. 
 
 
CRTCs: novel transcriptional players of multiple biological functions 
 
The brain is an exceptional regulator of body homeostasis due to its ability to sense, coordinate and 
respond to changes in the environment. How the brain regulates a variety of molecular signals that 
modulate brain-body communication (e.g., hormones, neurotransmitters…) is not fully understood. 
In the past decade, CRTC-dependent transcriptional control of gene expression has emerged as a 
central regulatory mechanism of cell and tissue function, whereas its deregulation is involved in 
cancer as well as immunological and age-related metabolic disorders [1]. Discovered as 
transcriptional regulators of CREB (see Glossary), CRTCs’ function is broader than initially 
expected. CRTCs regulate not only metabolic homeostasis in peripheral tissues but also maintain 
body energy balance by acting directly in the brain. Thus, CRTCs are unique signaling factors that 
act directly on brain function but also on brain-body communication by linking energy sensing and 
environmental signals with metabolism, circadian rhythm and synaptic function (Figure 1, Key 
Figure). In addition, CRTC1 connects synaptic activity with CREB-dependent transcription, a 
synapse-to-nucleus signaling process involved in neuronal development, survival, plasticity and 
regeneration [2, 3]. The diverse cellular actions of CRTCs contribute not only to regulate essential 
body functions but also brain physiology, including homeostasis, cognition and emotion. This 
review summarizes the most recent findings of CRTCs’ function in the brain, emphasizing their 
biology and regulatory mechanisms, their function on brain physiology, including metabolism, 
circadian rhythm, synaptic plasticity, memory and behavior. Finally, we discuss recent findings 
involving CRTCs in brain pathology, especially in psychiatric and neurodegenerative disorders, 
which eventually could lead to novel therapeutic avenues in age-related brain diseases. 
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CRTCs: structure and regulatory mechanisms 
 
CREB is a ubiquitous transcription factor that plays pleiotropic roles in the nervous system. It binds 
to conserved cAMP-response element (CRE) promoter consensus sequences of >5000 target genes 
as a homodimer or as heterodimers with other members of the CREB/ATF family of transcription 
factors [4, 5]. Multiple signaling pathways stimulate gene expression through CREB phosphorylation 
at Ser133, and the resulting recruitment of CBP/p300 coactivators, which activate transcription by 
acetylating nucleosomal histones and by interacting with factors of the general transcription 
machinery [6, 7]. CREB phosphorylation has thus long been considered as the critical event 
reflecting the activation of CRE-mediated transcription. However, several lines of evidence 
challenged this model and suggested that CREB can be activated independently of Ser133 
phosphorylation [8-10], which led to the discovery of the CRTC family of coactivators [11, 12]. The 
CRTC family comprises three members in mammals, with human CRTC2 and -3 sharing 32% 
amino acids identity with CRTC1 [12]. CRTC2 and CRTC3 are expressed in most tissues, whereas 
CRTC1 is mainly found in the brain [13-15]. CRTCs share a rather similar modular structure 
consisting of an N-terminal coil-coil CREB-binding domain, a central region containing several 
regulatory features, and a 200-amino acid-long C-terminal transactivation domain (Figure 2A). 
Unlike the CBP/p300 coactivators that interact with phosphorylated Ser133 in the kinase-inducible 
domain (KID) of CREB, CRTCs bind to its bZIP domain, which promotes CREB dimerization and 
DNA-binding. CRTCs are thus able to activate CREB independently of its phosphorylation status. 
 
Importantly, CRTCs do not constitutively activate CREB, as their subcellular localization is 
regulated by their phosphorylation state [16, 17]. In basal conditions, they are phosphorylated and 
sequestered in the cytoplasm by scaffolding 14-3-3 proteins and their nuclear translocation requires 
the concomitant activation of calcium and cAMP signaling pathways. Increase of intracellular 
calcium triggers CRTCs’ dephosphorylation by the Ca2+-dependent protein phosphatase 2B 
(PP2B)/calcineurin, whereas cAMP-activated PKA inhibits members of the AMPK family of 
Ser/Thr kinases (including SIKs, MARKs, and AMPK itself) that phosphorylate CRTCs, leading to 
their dissociation from 14-3-3 proteins and subsequent nuclear translocation (Figure 2B). In 
neurons, activity-dependent nuclear import of dendritic CRTC1 is critical for the transcription-
dependent phase of neuronal plasticity, although the underlying cellular and molecular regulatory 
mechanisms of its synapse-to-nucleus translocation are not completely understood [13, 14, 18-24]. 
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For instance, it is still debated whether PKA-mediated inhibition of SIKs is initially required for 
CRTC1 cytoplasmic release and nuclear translocation or whether SIKs inhibition prevents the 
rephosphorylation of nuclear CRTC1, thereby increasing its persistence in the nucleus [20]. Mass 
spectrometry analysis of CRTC1 revealed more than 10 Ser/Thr phosphorylation sites [22, 23], 
among which Ser151 was initially described as the main determinant of its subcellular localization 
[25]. However, calcineurin-mediated dephosphorylation of Ser151 is not always sufficient to induce 
nuclear translocation, thus suggesting the existence of additional regulatory phosphorylation sites. 
The number and identity of these sites were not clearly established until the recent emergence of a 
consensual model implicating the dephosphorylation of three conserved serine residues: Ser64, 
Ser151, and Ser245 [23]. These phosphorylation sites seem to confer a specific intensity of 14-3-3 
binding to each of the CRTC isoforms [26]. In addition to being phosphorylated, CRTCs are 
regulated by other post-translational modifications including acetylation, ubiquitination, 
glycosylation, and methylation [1, 4]. Nonetheless, these additional post-translational modifications 
have been mainly reported for CRTC2 in peripheral tissues, and their potential effects on CRTC’s 
functions in the nervous system remain as yet unclear. Moreover, accumulating evidence also 
suggests that CRTCs have broader roles beyond CREB-mediated transcription (Box 1), but their 
functional significance in the brain remains unknown. 
 
 
CRTCs regulate energy balance and lifespan  
 
The brain depends on glucose as its main source of energy, so glucose metabolism is crucial for 
brain function whereas its disruption is involved in the pathophysiology of brain disorders [27]. The 
brain, in turn, acts as a central regulator of body metabolism by controlling hormone and 
neuropeptides levels during appetite, nutrient intake and satiety. In this scenario, CRTCs have 
recently emerged as key molecules orchestrating gene changes regulating glucose and lipid 
homeostasis in peripheral tissues, including the liver, muscle, adipose tissue and pancreas [4], for a 
recent review. In the peripheral nervous system, CRTCs act as regulators of adaptive responses to 
exercise by integrating adrenergic and cholinergic signaling in sympathetic neurons and muscle. 
Indeed, catecholamines released from sympathetic neurons activate CRTC2/3/CREB-mediated 
transcription inducing glycogen and triglyceride catabolism in the skeletal muscle during intense 
exercise [28]. In the central nervous system, CRTCs coordinate energy balance by sensing and 
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responding to hormonal and nutrient signals (Figure 1). Adipocyte-derived leptin promotes satiety 
by activating leptin receptors in the arcuate nucleus of the hypothalamus. Leptin receptors induce 
Ser151 dephosphorylation and nuclear translocation of CRTC1 promoting CREB-dependent 
expression of the satiety neuropeptide cocaine- and amphetamine-regulated transcript (Cartpt) [25]. 
Indeed, Crtc1–/– mice show a leptin-resistant obese phenotype caused by increased appetite and food 
intake [25, 29]. Intriguingly, hyperphagic behavior and rapidly developing obesity appear only in 
Crtc1–/– males, whereas mutant females exhibit mild late-onset obesity without hyperphagia [30]. 
Furthermore, the male-specific hyperphagia is restricted to the resting (diurnal) phase of the light 
cycle and accompanied by a higher diurnal locomotor activity, thus suggesting that CRTC1 plays a 
gender-specific role in the central control of energy balance and circadian locomotor activity. 
Besides, feeding inhibits AMPK leading to CRTC2-dependent activation of Insulin receptor substrate 2 
(Irs2) and corticotropin-releasing hormone (Crh) genes in the hypothalamus [31], a result that 
contrasts with CRTC2 inactivation in response to feeding in the liver [32]. Nonetheless, CRTC2 is 
not able to compensate for loss of CRTC1 function in Crtc1–/– mice suggesting that the gene targets 
and/or physiological functions of CRTC family members may differ. 
 
Regulation of specific CRTCs by nutrient signals in the brain depends on the cellular and 
physiological contexts. In Drosophila, brain CRTC regulates energy balance during starvation by 
stimulating CREB target genes, including the short neuropeptide F (sNPF), an orthologue of 
mammalian neuropeptide Y implicated in maintenance of lipid and glycogen stores [33]. During re-
feeding, however, insulin inhibits CRTC activity by activating SIK2 in the brain [34]. Food 
deprivation induces nuclear accumulation and activation of CRTC in Drosophila neurons, which 
mediates appetitive long-term memory [35]. These studies indicate that CRTC family members 
regulate expression of genes involved in brain responses to nutrient sensing. 
 
Since CRTCs regulate energy homeostasis in response to nutrient signals, it is plausible that CRTCs 
modulate aging and longevity. Indeed, recent studies demonstrate a tight association between energy 
metabolism and aging, and several cellular pathways, including, among others, the mechanistic target 
of rapamycin (mTOR), AMPK and sirtuins, which mediate the effect of reduced energy intake on 
lifespan extension in lower organisms and mammals [36]. In C. elegans, activation of AMPK and 
calcineurin promotes longevity by inactivating the CRTC homologue CRTC-1 [37, 38]. Selective 
CRTC-1 activation in neurons is sufficient to suppress the effects of AMPK on systemic metabolism 
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and longevity acting through a cell-nonautonomous mechanism via regulation of catecholamine 
neurotransmission [38]. Notably, decreasing CRTC-1 expression extends lifespan, whereas 
inactivation of the CREB homologue crh-1 precludes lifespan extension caused by mutant CRTC-1 
suggesting a CREB-mediated effect [37]. Neuronal CRTC-1 mediates the effect of AMPK in 
longevity by modulating expression of genes involved in peripheral mitochondrial metabolism and 
dynamics, including genes regulated by the PPAR ortholog NHR-49 [38]. In contrast to these 
results, CRTC mutant flies live shorter and show reduced triglyceride and glycogen stores in 
response to starvation and oxidative stress, a phenotype reversed by overexpressing SIK or CRTC in 
neurons [34, 39]. In mice, activation of CRTC1/CREB signaling by the pain receptor transient 
receptor potential cation channel subfamily V member 1 (TRPV1) in dorsal root ganglia sensory 
neurons limits lifespan by increasing expression and secretion of the calcitonin gene-related peptide 
(CGRP), a molecule that restricts pancreatic insulin secretion and metabolic health in aging [40]. 
Together, these data suggest that neuronal CRTC regulates the crosstalk between metabolism and 
lifespan, although the neuronal subpopulations and CRTC-dependent gene programs involved in 
aging and longevity still require further investigation, especially in mammals.  
 
The circadian clock regulates rhythmic processes to maintain physiology, metabolism and behavior 
during day/night cycles. Several studies have highlighted the importance of CREB in regulating 
genes mediating circadian clock rhythms [2]. Interestingly, CRTC1 and CRTC2 are highly expressed 
in the suprachiasmatic nucleus (SCN) of the hypothalamus, the master circadian clock region. 
CRTC1, but not CRTC2, is increased in the middle of the day and decreased during the night in the 
mouse [41]. A light stimulus during the night period induces CRTC1 nuclear translocation and 
CREB transcriptional activation of period1 (Per1) and Sik1, the clock genes that synchronize the 
phase of circadian rhythms to body metabolism and behavior. In turn, SIK1-mediated CRTC1 
phosphorylation decreases Per1 in cellular circadian clock models and phase-shifting responses to 
light at circadian times (CT) 16-22 in mice, indicating that SIK1 suppresses the effects of light on the 
circadian rhythm entrainment by inactivating CREB/CRTC1 signaling [42]. It will be important in 
the future to discern the potential of modulating CRTC1 function to improve metabolic states and 
circadian rhythms in sleep and circadian clock-related diseases.  
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CRTCs in synapse morphology, function and plasticity 
 
Throughout life, the brain constantly reorganizes synaptic connections in response to environmental 
stimuli, experiences, and body signals. Long-lasting forms of neuronal plasticity are thought to 
depend on synapse-to-nucleus signaling and subsequent gene expression related to dendritic 
morphology, spine formation and synapse development [2]. Accordingly, CREB-dependent 
transcription of neuroplasticity genes is crucial for intrinsic and synaptic plasticity [3, 6, 43], and 
accumulating evidence also supports CRTC1’s involvement in neuronal plasticity processes, such as 
the maintenance of hippocampal late-phase LTP [13, 18, 44]. Late-LTP-eliciting stimuli and long-
term memory paradigms trigger CRTC1 dephosphorylation and nuclear translocation [18, 21, 22, 24]. 
Indeed, synaptic activity induces CRTC1 translocation from synapses to the nucleus triggering 
CREB-dependent gene transcription in neurons [20]. Activity-dependent transport of CRTC1 from 
dendritic spines to the nucleus of cultured rat hippocampal excitatory neurons requires local 
elevations of calcium triggered by activation of glutamate receptors and L-type voltage-gated calcium 
channels. Ca2+/calcineurin-mediated dephosphorylation of CRTC1 at serines 64, 151, and 245 
induces its dissociation from 14-3-3 proteins and migration from distal stimulated synapses to the 
nucleus through a mechanism involving the microtubule-based retrograde motor protein dynein and 
a conserved arginine-rich nuclear localization signal, independently of the classical importin /1-
mediated pathway [23, 45]. In these neuronal cultures, elevations of intracellular cAMP and 
activation of PKA are not required for the initial translocation of CRTC1 to the nucleus, but rather 
they increase the persistence of nuclear CRTC1 by inactivating SIKs and thus preventing its 
rephosphorylation [20]. In the nucleus, CRTC1 upregulates the expression of a subset of CREB 
target genes that includes, among others, the neurotrophic factor Bdnf, the immediate-early genes c-
fos, Zif268/Egr1, and Arc, the orphan nuclear receptors Nr4a1 and Nr4a2, and the brain-specific 
growth factor Fgf1 [18, 20-24, 44, 46-48]. Interestingly, all these genes have been involved in synaptic 
plasticity and memory formation. In agreement with the induction of these neuroplasticity genes, 
CRTC1-mediated gene transcription is required for activity- and BDNF-induced dendritic growth of 
developing cortical neurons [14, 19, 49]. More specifically, overexpressing CRTC1 in cultured rat 
cortical neurons increases basal as well as activity-induced dendrite length, whereas the 
downregulation of CRTC1 with a dominant-negative or by RNA silencing significantly reduced 
dendritic growth in cultured neurons and in the developing rat somatosensory cortex [8]. Similarly, 
BDNF-induced dendritic growth of rat cortical neurons requires CRTC1 nuclear translocation 
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resulting from activation of N-methyl-D-aspartate (NMDA) receptors by glutamate [13]. In 
summary, synapse-to-nucleus transport of CRTC1 is important to inform the nucleus about synaptic 
activity and induce the expression of neuroplasticity genes, whose products mediate plastic changes 
in dendrites and spines, thereby strengthening existing synaptic connections and facilitating the 
formation of new synapses. 
 
 
CRTCs in learning and memory  
 
It is well established that CREB controls gene expression programs essential for long-term synaptic 
plasticity and memory in a variety of organisms [6, 43, 50, 51], so acting as its transcriptional 
coactivators CRTCs are expected to modulate learning and/or memory. In Drosophila, CRTC is 
activated in mushroom body neurons by food deprivation mediating aversive and appetitive memory, 
whereas CRTC induces long-term memory and extends memory extinction [35, 52]. The transition 
from memory formation to maintenance is mediated by histone acetylation and shifting the 
transcriptional complex from CREB/CBP to CREB/CRTC [52]. Consistent with its role in CREB 
signaling, CRTC1 also mediates hippocampal-dependent long-term memory in mammals. Spatial 
and context associative learning induce CRTC1 activation in the hippocampus in a time- and 
stimulus-dependent manner [21, 22, 24, 44]. The regulatory mechanism of CRTC1 activation during 
learning involves calcineurin-dependent CRTC1 dephosphorylation and nuclear translocation in 
neurons of the hippocampus. Following associative learning, a complex containing phosphorylated 
CREB, CBP and CRTC1 is recruited to CRE-containing promoters that together with histone 
H3K14 acetylation induces transcription of synaptic plasticity and memory-related genes, such as 
Bdnf, c-fos, Nr4a1, Nr4a2 and Fgf1 [24, 44]. CRTC1 sustains memory formation as revealed by 
memory enhancement in mice overexpressing wild-type or constitutively active S151A/S245A or 
S151A/S167A mutants [22, 24, 44, 53]. Additionally, CRTC1 inactivation in the hippocampus 
impairs hippocampal LTP and long-term contextual fear memory, a phenotype prevented by 
overexpressing CRTC1 but not a cytosolic CRTC1 mutant, indicating that CRTC1 nuclear 
translocation is essential for memory consolidation [44]. In agreement with a CREB-dependent 
mechanism, disruption of CREB/CRTC1 association impairs CREB-dependent transcription, 
synaptic plasticity and long-term memory [49]. Although regulation of neuroplasticity genes is critical 
for CRTC1’s function in synaptic plasticity and memory, it is unclear whether CRTC1 mediates 
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long-term memory by regulating synapse-to-nucleus signaling, synaptic plasticity and/or unknown 
pre- or post-synaptic mechanisms. A more precise understanding of the cellular and molecular 
mechanisms by which CRTCs regulate synaptic function and plasticity is thus critical to better 
discern their implication in memory. 
 
 
CRTC1 in neurodegenerative diseases 
 
CREB signaling dysfunction is involved in degeneration and memory deficits in neurodegenerative 
diseases [54]. In agreement with its role in CREB signaling, CRTC mediates neuroprotection in 
neurodegenerative diseases. In Huntington’s disease (HD), dominant inherited mutations in the 
huntingtin (Htt) gene cause death of striatal medium spiny neurons leading to motor alterations. 
Notably, CRTC1 is reduced in the striatum of HD [55], and mutant Htt inactivates CRTC1, which 
likely contribute to neurodegeneration by repressing BDNF expression [56]. The Sirt1 deacetylase 
mediates neuroprotection and ameliorates motor deficits by activating CRTC1 in transgenic HD 
mouse models [56]. CRTC1 inactivation in the striatum of Htt transgenic mice induces 
neurodegeneration, whereas CRTC1 overexpression reduces mitochondrial toxicity by increasing 
PGC-1 expression [55]. Besides its role in neurodegeneration, decreased expression of 
CREB/CBP/CRTC1 target genes in the hippocampus is associated with long-term memory deficits 
in HD mice [57], which suggests a possible link between CRTC1 dysfunction and memory deficits in 
HD.  
 
Parkinson´s disease (PD) is caused by dysfunction and loss of dopaminergic neurons in the 
substantia nigra pars compacta, which leads to motor impairments. It has been shown that neuronal 
p21-activated kinase 4 (PAK4) protects from neurodegeneration and motor dysfunction caused by 
6-hydroxydopamine (6-OHDA) and α-synuclein in PD rat models [58]. PAK4 mediates 
neuroprotection by phosphorylating CRTC1 at Ser215 and inducing the expression of CREB target 
genes, including Bcl-2, Bdnf, and Pgc-1. Levels of active pCRTC1 Ser215, but not those of total 
CRTC1, are significantly reduced in the substantia nigra of PD patients, as well as after 6-OHDA 
treatment or α-synuclein overexpression in rats [58]. These results indicate that CRTC1 
phosphorylation at Ser215 is critical for PAK4-neuroprotection, although it is still unclear whether 
this mechanism is involved in the etiopathogenesis of PD or other neurodegenerative diseases. 
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Alzheimer’s disease (AD), the main cause of dementia worldwide, is characterized by degeneration 
of neurons and synapses, and abnormal accumulation of -amyloid (A) peptides and 
phosphorylated tau in memory circuits. Deregulation of CREB/CRTC1 signaling was recently 
reported in brains of AD patients and mice. Thus, a CRTC1/CREB-dependent gene transcriptional 
program related with synapse function and plasticity is deregulated at early pathological and 
cognitive stages in APPSw,Ind transgenic mice [21]. Impaired CRTC1 function coincides with 
intraneuronal A accumulation suggesting that aggregated pre-plaque A may perhaps lead to 
CRTC1 inactivation [21, 59]. The mechanism by which A mediates CRTC1 inactivation involves  
impaired Ca2+/calcineurin-mediated CRTC1 dephosphorylation and reduced nuclear translocation 
and occupancy of CREB target gene promoters [21, 46], which eventually leads to downregulation 
of neuroplasticity, memory and neuroprotection genes (Figure 3). In addition, reduced calcium 
influx or mobilization from intracellular stores might be responsible for disruption of CRTC1 
transcriptional function caused by loss of presenilin function, as observed in a neurodegeneration 
mouse model [24]. Importantly, CRTC1 overexpression using a gene therapy approach ameliorates 
early transcriptional and memory impairments in AD and neurodegeneration mouse models, 
suggesting that increasing CRTC1 activity may be beneficial against cognitive decline in AD [21, 24]. 
Nevertheless, epileptic drugs induce CRTC1 nuclear translocation in the hippocampus, indicating 
that CRTC1 overactivation caused by aberrant excitability may be counterproductive [60]. Notably, 
CRTC1 protein and mRNA are reduced at moderate stages of AD [21, 61]. CRTC1 promoter 
methylation inversely correlates with phosphorylated tau accumulation but not amyloid deposition, 
suggesting a possible link between tau pathology and CRTC1 deregulation [61]. Future studies will 
be necessary to discern whether CRTC1 contributes to cognitive impairments and pathological 
hallmarks in AD and other dementing disorders. 
 
 
CRTCs dysregulation in psychiatric disorders 
 
Altered neuronal plasticity and cognitive impairments are common pathophysiological features of 
many psychiatric disorders [62]. By affecting neuroplasticity at several levels, chronic stress strongly 
contributes to the development of psychiatric illnesses [63]. Notably, CREB and BDNF are critically 
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involved in these processes [64, 65]. Consistent with CRTCs’ role in CREB signaling and Bdnf gene 
expression, emerging evidence suggests that CRTCs dysregulation may be implicated in the 
etiopathogenesis of psychiatric disorders, such as addiction, anxiety and mood disorders. There is 
compelling evidence of HPA axis dysfunction in stress-related psychiatric disorders. CRF produced 
in the hypothalamic paraventricular nucleus (PVN) is the main regulator of HPA axis activity during 
stress, and tightly controlled CRF levels are required for a proper stress response. Crf transcription 
depends on CRTC2 and CRTC3 in rat and mouse PVN [66, 67]. Given the strong evolutionary 
conservation of the HPA axis regulation, one can reasonably speculate that altered levels or activity 
of CRTCs in human PVN might impinge on HPA axis function, and possibly participate in the 
development of psychiatric disorders. 
 
Drug addiction is considered to be a disorder of neuroplasticity caused by cellular and molecular 
alterations in brain reward systems. Rats with a history of extended cocaine access show an 
escalation of cocaine consumption triggered by neuroplastic changes in the striatum. Interestingly, 
only a vulnerable fraction of human cocaine users or rats with extended cocaine access (~15%) loses 
control over intake and develops compulsive drug-seeking behaviors. The large majority of rats not 
exhibiting addiction-like behaviors are protected by a mechanism involving microRNA-212-
enhanced Raf1 activity, resulting in adenylyl cyclase sensitization, and increased CREB 
phosphorylation and CRTC1 levels in the dorsal striatum [68]. Lentivirus-mediated overexpression 
of CRTC1 in dorsal striatal neurons indeed protects rats with extended cocaine access from 
escalating their cocaine consumption. Although this interesting finding awaits further confirmation 
by other studies, it suggests that this coactivator might play a key role in determining vulnerability to 
drug addiction. 
 
Depressive and bipolar disorders, collectively referred to as mood disorders, are the most common 
forms of psychiatric disorders and, according to World Health Organization, the leading cause of 
disability worldwide. Although several classes of antidepressants are available, a substantial 
percentage of patients are unresponsive to these medications, calling for a better understanding of 
the neurobiology of depression. Increasing evidence suggests that brain neuroplasticity is disrupted 
in mood disorders, which is supported by the involvement of CREB and BDNF in major depressive 
disorder and rodent models of depression [63, 64, 69, 70]. In keeping with CRTC1’s role in neuronal 
plasticity processes, Crtc1–/– mice exhibit depressive-like behaviors and neurobehavioral 
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endophenotypes related to mood disorders [39]. Concomitantly, the expression of several 
susceptibility genes, including Bdnf, its receptor TrkB, the nuclear receptors Nr4a1-3, and several 
other CREB-regulated genes is decreased in the prefrontal cortex and hippocampus, which suggests 
an altered neuroplasticity in these structures. Moreover, mutant mice display a blunted response to 
classical antidepressants [47, 71], which indicates that CRTC1 is required for a normal antidepressant 
response in mice. Interestingly, the HDAC inhibitor SAHA improves the depressive-like behavior 
of Crtc1–/– mice and restores Bdnf expression in their prefrontal cortex, which suggests that an 
epigenetic approach rescuing CRTC1-mediated neuroplasticity gene expression could be a useful 
antidepressant strategy [71]. A cDNA microarray study attempting to identify altered gene 
expression in the cortex of Crtc1–/– mice revealed an upregulation of agmatinase, the enzyme 
degrading the arginine-decarboxylation product agmatine [72]. Accumulating evidence implicates the 
agmatinergic system in brain pathology, notably in mood disorders, since post-mortem studies have 
shown increased agmatinase levels in brain tissues from depressed individuals [73, 74]. Acute and 
chronic stress decrease agmatine levels in rodent forebrain and exogenous agmatine has rapid 
antidepressant effect in animal models of depression. Hence, the depressive-like phenotype of Crtc1–
/– mice is improved by acute agmatine treatment, which supports a causal role of the deregulated 
agmatinergic system in this mouse model of depression, as it was suggested for human depression 
[72, 74]. The relationship between CRTC1 and agmatinase regulation is still elusive and merits 
further investigation, as it should provide further insight into their role in psychiatric disorders, 
notably in human major depression. A recent study did not show a genetic association between 
CRTC1 polymorphisms and major depressive disorder [75]. Nonetheless, in keeping with the shared 
etiological pathways of psychiatric disorders and obesity, CRTC1 polymorphisms play a role with 
obesity markers in psychiatric cohorts and individuals with major depression [75, 76]. The absence 
of direct genetic association between CRTC1 and depression in these studies does not however rule 
out the possibility that other CRTC1 genetic variants might be associated with mood disorders or 
other psychiatric disorders. 
 
 
Concluding Remarks 
 
Compelling evidence that CRTCs play a crucial role in brain plasticity has accumulated over the past 
ten years. The recent progress described above indicates that activity-dependent synapto-nuclear 
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transport of CRTC1 is instrumental in conveying information from remote dendritic post-synaptic 
compartments to the nucleus, where it increases the expression of CREB target neuroplasticity genes. 
Acting as important sensors and integrators of hormonal, metabolic, and neural signals, CRTCs 
regulate essential brain functions and many aspects of reciprocal brain-body communication (Table 
1). However, many features of CRTCs’ brain function and regulation remain elusive (see 
Outstanding Questions). For instance, CRTCs play crucial roles in brain plasticity and brain-body 
communication by regulating the expression of CREB target genes, but CRTCs’ functions 
dependent or independent of gene transcription at synapses or other neuronal compartments require 
further investigation. Future studies aiming at further understanding these mechanisms should lead 
to better insight into the possible involvement of CRTCs’ deregulation in cognitive, 
neurodegenerative and psychiatric disorders. Ultimately, it is tantalizing to envision the future 
development of novel treatment strategies targeting the CRTC signaling pathway. 
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Glossary 
 
AMPK family: the AMP-activated protein kinase (AMPK) is an important energy sensor of 
intracellular ATP levels. It is activated when AMP levels increase in response to a lowering of ATP 
levels. Other members of the AMPK family include the salt-inducible kinases (SIKs) and 
microtubule affinity regulating kinases (MARKs), whose activity is not regulated by AMP levels. 
 
-amyloid (A): 39-43 amino acid-long peptides generated by sequential cleavage of the amyloid 
precursor protein (APP). -amyloid is accumulated in amyloid plaques in the brain of Alzheimer´s 
disease patients. Abnormal accumulation, aggregation and deposition of -amyloid are thought to 
contribute to degeneration of neurons in Alzheimer´s disease. 
 
CBP/p300 coactivators: CREB-binding protein (CBP) and p300 are closely related transcriptional 
coactivators that interact with numerous transcription factors. They activate transcription through 
their intrinsic histone acetyltransferase activity and by helping to recruit components of the general 
transcriptional machinery to gene promoters. 
 
CREB: the cAMP-response element (CRE) binding protein (CREB) is a 43 kDa transcription factor 
that binds to the highly conserved palindromic CRE consensus sequence 5´-TGACGTCA-3´ of 
target gene promoters. CREB belongs to the bZIP superfamily of transcription factors that are 
characterized by a leucine zipper domain that mediates dimerization and a C-terminal basic region 
that binds to the DNA. Several cellular signals converge to activate CREB-mediated gene 
transcription into the nucleus. 
 
CRH or CRF: corticotropin-releasing hormone (CRH), also called corticotropin-releasing factor 
(CRF), is a 41-amino acid peptide that is the primary regulator of the mammalian stress response. 
CRH is secreted by the paraventricular nucleus of the hypothalamus in response to stress and 
activates the hypothalamic-pituitary-adrenal (HPA) axis, leading to a release of glucocorticoids from 
the adrenal gland cortex. 
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SAHA: Suberoylanilide hydroxamic acid (also known as vorinostat) is a compound that inhibits 
class I and II histone deacetylases (HDACs). Systemic administration of SAHA increases histone 
acetylation in the brain and has antidepressant effects in mice. 
 
Synaptic plasticity and LTP: Synaptic plasticity refers to structural and functional modifications of 
synapses resulting in changes in synaptic efficacy. One cellular form of synaptic plasticity is long-
term potentiation (LTP), which involves persistent strengthening of synaptic response following 
high-frequency stimulation. Long-lasting synaptic plasticity mediated by neuronal activity requires 
transcription of gene programs. Importantly, neuronal plastic changes that persist for days or longer 
as a result of learning and training induce memory formation. 
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Box 1. Emerging roles for CRTCs beyond CREB coactivation 
 
There is growing evidence that CRTCs’ functions are not restricted to CREB coactivation. CRTC1 
has the capacity to bind to the bZIP domain of c-Fos and c-Jun, forming the AP-1 transcription 
factor, thereby promoting cell proliferation and transformation [77]. Given the importance of Fos 
family members (c-Fos, FosB, FosB) in brain plasticity processes, it remains to determine whether 
CRTC1 is also coactivating AP-1-mediated transcription in the brain. Linking endoplasmic reticulum 
(ER) stress and fasting gluconeogenesis, CRTC2 interacts with the bZIP transcription factor ATF6, 
which results in a decrease of CREB-mediated gluconeogenic genes expression [78]. Further 
suggesting a more general role in transcription beyond CREB, it was recently shown that CRTC2 
modulates the transcriptional activity of the glucocorticoid and progesterone receptors in liver cells 
[79], thus raising the interesting possibility that CRTCs might act as coactivators of the nuclear 
receptor superfamily in various tissues, including the brain. 
Besides their transcriptional coactivator function, CRTCs have additional roles in RNA splicing 
regulation and ER-Golgi trafficking. Depending on the cell type or promoter context, CRTCs 
coordinately or independently regulate transcription and alternative pre-mRNA splicing of CRE-
containing genes, such as for instance Nr4a2 [80]. CRTC1-dependent alternative splicing is mediated 
by a functional domain distinct from the C-terminal transactivation domain (Figure 2A). In addition 
to these expanding new functions, CRTC2 has been shown to play a role in hepatic lipid metabolism 
by regulating vesicle trafficking from the ER to the Golgi and the resulting processing of Sterol 
Regulatory Element-Binding Protein 1 [81]. Taken together, these emerging new roles of CRTCs 
beyond CREB coactivation highlight the diversity of the cellular processes involving these 
coactivators. Future studies should provide further insight into their potential importance in the 
brain. 
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Outstanding Questions 
 
The localization of CRTC1 at different neuronal compartments, such as cytosol, nucleus, dendrites 
and synapses, raises the possibility that CRTC1 may be involved in multiple functions depending on 
its subcellular location. Why CRTC1 is located at synapses? Does CRTC1 play a role at synapses 
independently of its transcriptional function? Is CRTC1 function at synapses dependent or 
independent of its transcriptional activity? 
 
CRTC1 regulates functional and structural synaptic plasticity in the hippocampus. Which are the 
specific molecular mechanisms regulated by CRTC1 during synaptic plasticity? Does CRTC1 
regulate presynaptic or postsynaptic mechanisms during synaptic plasticity? Does CRTC1-dependent 
synaptic plasticity mediate memory encoding or storage? 
 
Deregulation of CRTC1 occurs in several neurodegenerative and psychiatric disorders. Is there a 
common mechanism leading to disruption of CRTC1/CREB pathway in these disorders? Is CRTC1 
affecting specific or common pathological hallmarks in these brain disorders? Are deregulated 
CRTCs perturbing adult hippocampal neurogenesis that is involved in memory, cognitive function 
and mood regulation? Importantly, are CRTC1-based therapeutic strategies beneficial to ameliorate 
pathological and behavioral changes in brain diseases? 
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Table 1. Physiological and pathological processes involving CRTCs in the brain. 
CRTC 
isoform 
Organism 
Cell type or brain 
region 
Physiological process 
or pathology 
Refs 
CRTC1 Mouse Hypothalamus 
Central regulation of 
energy balance 
[25, 29, 30] 
 Human ? 
Obesity in psychiatric 
cohorts 
[75, 76] 
 Mouse 
Spinal cord 
sensory neurons 
Pain, metabolic health, 
lifespan 
[40] 
 Mouse 
Suprachiasmatic 
nucleus 
Circadian rhythm [41, 42] 
 Rodents 
Cortical and 
hippocampal 
neurons, 
hippocampus 
Activity-dependent 
nuclear translocation, 
neuronal plasticity, 
L-LTP maintenance 
[13, 14, 18-20, 
23, 44, 49] 
 Mouse 
Hippocampus, 
amygdala 
Long-term memory 
[21, 22, 24, 44, 
53] 
 
Human, 
mouse 
Striatum, cortex Huntington’s disease [55, 56] 
 
Human, 
rat 
Substantia nigra Parkinson’s disease [58] 
 
Human, 
rodents 
Hippocampus Alzheimer’s disease 
[21, 24, 46, 59, 
61] 
 Rat Hippocampus Epilepsy [60] 
 Rat Striatum Cocaine addiction [68] 
 Mouse 
Prefrontal cortex, 
hippocampus 
Mood disorders, 
treatment-resistant 
depression 
[47, 71, 72] 
CRTC2 Mouse Hypothalamus Glucose sensing [31] 
 Rodents Hypothalamus 
Crf expression, stress 
response 
[66, 67] 
CRTC3 Rodents Hypothalamus Crf expression, stress [66, 67] 
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response 
CRTC Drosophila Brain 
Central regulation of 
energy balance 
[33, 34, 39] 
   
Appetitive long-term 
memory 
[35, 52] 
CRTC-1 C. elegans Neurons 
Central regulation of 
metabolism and lifespan 
[37, 38] 
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Figure Legends 
 
 
Figure 1. Key Figure. Physiological functions of CRTCs in the central and peripheral 
nervous system. CRTC family members modulate key physiological processes in the central and 
peripheral nervous system by regulating CREB-dependent gene transcription. The left image depicts 
the brain regions (black arrows) and target peripheral organs (blue arrows), the cellular processes and 
target genes (italic) or proteins (capital letters) regulated directly or indirectly by CRTCs in mammals. 
Light blue arrows indicate transcriptional function of CRTCs in the brain, and dark blue arrows 
represent CRTC action directly in peripheral nerves or organs. For instance, CRTC1 promotes 
expression and release of the CGRP neuropeptide in dorsal root ganglion neurons targeting insulin 
secretion in the pancreas, and catecholamines released from sympathetic neurons activate CRTC2/3 
in skeletal muscle during intense exercise. The right picture shows the cellular and physiological 
processes regulated by brain CRTC in C. elegans and Drosophila. Details of central and peripheral 
actions of CRTCs and references are described in the text. Images were freely provided by the 
Library of Science and Medical Illustrations. 
 
Figure 2. Structure and regulation of CRTC1, the major brain isoform of the CRTC family. 
(A) CRTC1 comprises an N-terminal CREB-binding domain (CBD) followed by a central regulatory 
region containing a nuclear localization sequence (NLS), two nuclear export sequences (NES1, 
NES2) and a splicing domain (SD) preceding the C-terminal transactivation domain (TAD). CRTC1 
phosphorylation at Ser64, Ser151, and Ser245 by members of the AMPK family of Ser/Thr kinases 
(SIK1/2, MARK2, AMPK) promotes association with 14-3-3 proteins and cytoplasmic retention. 
Acetylation of several lysine residues (Lys 13, 20, 33, 178, 197) in CRTC1 has been reported [56], but 
its putative regulatory role is still unclear and awaiting further investigation. The numbers refer to 
the amino acid sequence of mouse CRTC1 protein. (B) Regulation of CRTC1 activity by Ca2+ and 
cAMP signals. Neuronal activity triggers Ca2+ influx through L-type voltage-gated calcium channels 
(L-VGCC), leading to calcineurin (CaN) activation and CRTC1 dephosphorylation. In addition, 
stimulation of adenylate cyclase (AC) by G protein-coupled receptors increases cAMP levels and 
activates PKA, which inhibits members of the AMPK family such as SIK. Dephosphorylated 
CRTC1 translocates to the nucleus and promotes expression of specific CRE-containing target 
genes.  
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ATP: adenosine triphosphate; Ca2+: calcium; cAMP: cyclic adenosine monophosphate; CBP: CREB-
binding protein; CRE: cAMP response element; SIK: salt-inducible kinase; TBP: TATA box-binding 
protein. 
 
 
Figure 3. Molecular mechanisms of disruption of CRTC1 signaling in Alzheimer´s disease. 
Schematic cellular model depicting disruption of activity-induced CRTC1/CREB-dependent gene 
transcription by A pathology and presenilin genes during pathological events in Alzheimer´s 
disease. Abnormal accumulation of intracellular and/or extracellular A oligomers in neurons 
negatively impact on neuronal activity resulting in altered function of neurotransmitter GPCRs and 
L-VGCCs leading to reduced cAMP and Ca2+ levels. The resulting impaired activation of calcineurin 
decreases CRTC1 dephosphorylation and nuclear translocation. On the other hand, loss of 
presenilin function in neurons of the postnatal forebrain is known to impair glutamate 
neurotransmission, which reduces intracellular Ca2+ levels mobilized from NMDAR and ER stores. 
PS inactivation reduces CRTC1 dephosphorylation, nuclear translocation, and transcriptional 
function.  The physiological effects of A accumulation and PS inactivation are a disruption of 
CRTC1/CREB target genes in neurons. 
14-3-3: 14-3-3 adapter protein; A: -amyloid; AC: Adenylate cyclase; CBP: CREB binding protein; 
CaN: calcineurin; ER: endoplasmic reticulum; GPCR: G-protein coupled receptor; L-VGCC: L-type 
voltage-gated calcium channel; NMDAR: N-methyl-D-aspartate receptor; PS: presenilin; RyR: 
Ryanodine receptor; SIK: salt-inducible kinase. 
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